logo

For the Inventor, By the Inventor

Gothenburg, Sweden

Isofol Medical Ab

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 30.0



Forward Citations = 16

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Bengt Gustavsson (9 out of 18 patents)

silverMedal Anders Vedin (6 out of 6 patents)

bronzeMedal Göran U Carlsson (5 out of 5 patents)

4.  Yvonne Wettergren (4 out of 4 patents)

5.  Elisabeth Odin (4 out of 4 patents)

6.  Per L Lindberg (3 out of 3 patents)

7.  Gunnel E Sundén (3 out of 5 patents)

8.  Björn Carlsson (1 out of 1 patent)

9.  Karin Ganlöv (0 patent)

10.  Per Lennart Lindberg (0 patent)

11.  Bengt Gustavsson (0 patent)

12.  Goran Carlsson (0 patent)

13.  Magnus ÖStberg (0 patent)

14.  Gunnel Elisabet SUNDÉN (0 patent)

15.  Göran Carlsson (0 patent)


10 patents:

1. 12527796 - [6R]-MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy (2026-01-20),
2. 11389452 - Methods for increasing blood plasma 2'-deoxyuridine (dUrd) and thymidylate synthase inhibition (2022-07-19),
3. 11013744 - [6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy (2021-05-25),
4. 10639311 - Methods for increasing blood plasma 2'-deoxyuridine (dUrd) and thymidylate synthase inhibition (2020-05-05),
5. 10487364 - Administration regime (2019-11-26),
6. 10328079 - [6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy (2019-06-25),
7. 10292984 - Methods for increasing blood plasma 2'-deoxyuridine (dUrd) and thymidylate synthase inhibition (2019-05-21),
8. 9675617 - Tetrahydrofolates in combination with EGFR-inhibitors (2017-06-13),
9. 9585888 - Reduction of toxicity of multi-targeting antifolates (2017-03-07),
10. 9138435 - Reduction of toxicity of multi-targeting antifolates (2015-09-22),
Company Overview
Isofol Medical AB is a biotechnology company based in Gothenburg, Sweden, specializing in the development of innovative cancer therapies. The company focuses on advancing its proprietary drug candidate, which aims to enhance the efficacy of existing cancer treatments while minimizing side effects. Isofol's research primarily targets the optimization of folate-based therapies, leveraging its expertise in oncology to address unmet medical needs in cancer care. Through its commitment to scientific excellence, Isofol seeks to improve patient outcomes in the fight against cancer.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#56 in Gothenburg

#594 in Sweden

#56,119 in the World

Gothenburg, SE
Gothenburg, Sweden

Isofol Medical Ab

Forward Citations = 16

8 inventors:

goldMedal Bengt Gustavsson (9 out of 18 patents)

silverMedal Anders Vedin (6 out of 6 patents)

bronzeMedal Göran U Carlsson (5 out of 5 patents)

4.  Yvonne Wettergren (4 out of 4 patents)

5.  Elisabeth Odin (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Isofol Medical Ab. Retrieved from https://idiyas.com/company/isofol-medical-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…